1. Home
  2. PKE vs MYGN Comparison

PKE vs MYGN Comparison

Compare PKE & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$24.36

Market Cap

463.2M

Sector

Industrials

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.11

Market Cap

547.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
MYGN
Founded
1954
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.2M
547.2M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
PKE
MYGN
Price
$24.36
$5.11
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$10.67
AVG Volume (30 Days)
346.6K
938.2K
Earning Date
01-13-2026
02-23-2026
Dividend Yield
2.09%
N/A
EPS Growth
19.30
N/A
EPS
0.43
N/A
Revenue
$66,053,000.00
$825,300,000.00
Revenue This Year
N/A
$0.05
Revenue Next Year
N/A
$5.54
P/E Ratio
$55.65
N/A
Revenue Growth
7.54
0.21
52 Week Low
$11.97
$3.76
52 Week High
$26.12
$15.47

Technical Indicators

Market Signals
Indicator
PKE
MYGN
Relative Strength Index (RSI) 55.94 27.66
Support Level $23.57 $5.03
Resistance Level $25.51 $5.70
Average True Range (ATR) 0.99 0.28
MACD -0.19 -0.05
Stochastic Oscillator 39.11 8.93

Price Performance

Historical Comparison
PKE
MYGN

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: